Table 1.
Intron gains identified with a purportedly known mechanistic origin
| Proposed mechanism | In vivodemonstration | Indirect evidence | Number of events unambiguously identified | Specie(s) event identified in |
|---|---|---|---|---|
| Intron Transposition |
No |
Yes [25,44] |
14 |
Mycosphaerella, Oikopleura |
| Transposon Insertion |
No |
Yes [23,25,54,55] |
35 |
Oryza, Drosophila, Oikopleura, Zea |
| Tandem Genomic Duplication |
Yes [56] |
Yes [18,57] |
188 |
Arabidopsis, Oryza, Caenorhabditis, Drosophila, mouse, human, Cryptococcus |
| Intron Gain during DSBR |
No |
Yes [22,23,27,58,59] |
5 |
Drosophila, Daphnia, Aspergillus, Bigelowiella, human |
| Intron Transfer |
No |
Yes [22,31,44] |
3 |
Mycosphaerella, Aspergillus, Chironomus, |
| Insertion of a Group II Intron |
Likely does not occur [60] |
No |
0 |
|
| Intronization | No | Yes [41,42,61,62] | 29 | Cryptococcus, Caenorhabditis |
Only intron gains with novel splice sites (i.e. not simple duplications of pre-existing introns) were included. Only novel introns with EST support were selected from [57]. For a more detailed treatment of events, see the MIGL database located at http://cpath.him.pitt.edu/intron/index.php (manuscript in preparation).